J. Zhang

5.9k citations

38 papers · 413 indexed · h-index 8

Cancer Research
- Cancer Genomics and Diagnostics 9
Oncology
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 5
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 7
Cell Biology
Molecular Biology
- RNA modifications and cancer 4
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 3
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 3

Co-authors: John V. Heymach David S. Hong Niamh Coleman Lingzhi Hong Xiuning Le Na Niu Jian Kuang Ning Zhang
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Partner nations: United States China Australia

In The Last Decade

J. Zhang

34 papers receiving 402 citations

Peers

Countries citing papers authored by J. Zhang

Since Specialization

Citations

This map shows the geographic impact of J. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Zhang more than expected).

Fields of papers citing papers by J. Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Zhang. The network helps show where J. Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Zhang Line = papers co-authored together J. Zhang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Imposter syndrome across surgical subspecialties: scratching the surface R.F. Brown,Tasha Posid,Sarah Lund,Amanda Cooper,Joseph C. L’Huillier,Olabisi Ololade Sheppard,Esther Wu,J. Zhang,Sophia K. McKinley,Theofano Zoumpou,Minna M. Wieck,Christie Bialowas,Kimberly Hendershot	2025	0
2	LBA54 SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade Adam Grippin,Cecilia Marconi,Sage Copling,N. Li,Christian Braun,C. Woody,Erin L. Young,Priti Gupta,DNB Team,Ryan Sun,Padmanee Sharma,J. Zhang,D. Gibbons,Jennifer A. Wargo,Y.S.B. Kim,J. Heymach,Héctor Méndez-Gómez,Wen Jiang,Elias Sayour,Shiaw‐Yih Lin	2025	0
3	995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade Adam Grippin,Sage Copling,Alexander Kim,Erin L. Young,Rishabh Lohray,Ellen T. Chang,Ramez Kouzy,Jeff Lewis,Xiaolin Wei,W. Rinsurongkawong,Jih‐Jong Lee,D. Gibbons,Ara Vaporciyan,Hai T. Tran,Y.S.B. Kim,John V. Heymach,J. Zhang,Elias Sayour,Wen Jiang,Steven H. Lin	2024	2
4	615MO Phase I/II study of D3S-001, a second generation KRAS G12C inhibitor in advanced/metastatic solid tumors with KRAS G12C mutations B.C. Cho,Shaolei Lu,M.A. Lee,Zixuan Song,J.J.W. Park,Seungtaek Lim,Zhen Li,Jing Zhao,Gerry Richardson,Y. Zhang,J. Zhang,A. Liu,Chunying Chen,Jing Wang,Junru Chen,Aiguo Wang,J. Zhang,Zhengtai Chen,T.S.K. Mok,M.L. Johnson	2024	4
5	1242MO The addition of belomethason propionate inhalation to radical radiotherapy for patients with locally advanced non-small cell lung cancer: A randomized controlled, open-label phase II study J. Zhang,Qiu Wu,Hua Wu,Weidong Zhao,Mingsong Shi	2024	2
6	Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer Hai T. Tran,Simon Heeke,Sheeba J. Sujit,Natalie I. Vokes,J. Zhang,Muhammad Aminu,Vincent K. Lam,Ara A. Vaporciyan,Stephen G. Swisher,Myrna C.B. Godoy,Tina Cascone,Boris Sepesi,Don L. Gibbons,Jia Wu,John V. Heymach	2023	32
7	MA15.04 Timing of Pre-Biopsy COVID-mRNA Vaccination and PD-L1 Expression in Advanced Non-Small Cell Lung Cancer Adam Grippin,Brian De,Katharina Fink,David A. Swanson,Charles Y.F. Young,Ellen T. Chang,Amber L. Johns,Edward Cha,Xu Wei,Stephanie O. Dudzinski,Jeff Lewis,W. Rinsurongkawong,V. Rinsurongkawong,J. Jack Lee,J. Zhang,D.L. Gibbons,A.A. Vaporciyan,John V. Heymach,Steven H. Lin	2023	1
8	Pancreatic Ductal Adenocarcinoma Immune and Stromal Elements Differ in Spatial Distribution Based on Response to Chemoradiation Mohamed Zaid,Sonja M. Woermann,Baishali Chaudhury,C.P. Thunshelle,Annie Dai,Anshuman Agrawal,L. Widmann,J. Zhang,Mark W. Hurd,Gauri R. Varadhachary,Matthew H. G. Katz,Joseph M. Herman,Andrew D. Rhim,Eric P. Tamm,Eugene J. Koay	2020	1
9	MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC) Loretta A. Williams,Qiuling Shi,Belqis El Ferjani,M. Hirschmann,Darcy Ponce,Seyedeh Dibaj,Sheenu Chandwani,Emily Roarty,Waree Rinsurongkawong,Jeff Lewis,Thomas Burke,Charles S. Cleeland,Jes Chauviere Lee,Jack A. Roth,S. Swisher,John V. Heymach,J. Zhang,George R. Simon	2019	1
10	P1.01-98 Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing Hai T. Tran,Vincent K. Lam,M. Vasquez,Lingzhi Hong,Rivka R. Colen,Nabil Elshafeey,Islam Hassan,Vassiliki A. Papadimitrakopoulou,George R. Blumenschein,B. Carter,George R. Simon,Richard B. Lanman,Victoria M. Raymond,Yasir Y. Elamin,Mehmet Altan,Anne S. Tsao,Don L. Gibbons,J. Zhang,John V. Heymach	2019	1
11	P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer Loretta A. Williams,Shiva Dibaj,Sheenu Chandwani,Viralkumar Vaghani,Qiuling Shi,M. Hirschmann,L.L. Landry,Emily Roarty,J. Zhang,W. Rinsurnogkawong,Jeffery D. Lewis,Thomas Burke,Charles S. Cleeland,Jes Chauviere Lee,Jack A. Roth,S. Swisher,John V. Heymach,George R. Simon	2018	1
12	OA03.05 Characterization of the Immunologic Intra-Tumor Heterogeneity in Early Stages of Non-Small Cell Lung Cancer by Multiplex Immunofluorescence Alejandro Francisco‐Cruz,Edwin R. Parra,Mei Jiang,Junya Fujimoto,Santhoshi Krishnan,Souptik Barua,Arvind Rao,Chi-Wan Chow,Carmen Behrens,Neda Kalhor,Annikka Weissferdt,John V. Heymach,Stephen G. Swisher,Boris Sepesi,Jehee Lee,César A. Moran,P. Andrew Futreal,J. Zhang,Ignacio I. Wistuba	2018	2
13	P2.04-09 Driver Mutations are Associated with Distinct Patterns of Response to Immune Checkpoint Blockade in Non-Small Cell Lung Cancer Marcelo V. Negrão,Alexandre Reuben,Jacqulyne Robichaux,Xiuning Le,Monique B. Nilsson,Yasir Y. Elamin,Chang‐Jiun Wu,J. Zhang,L.L. Landry,Emily Roarty,Waree Rinsurongkawong,Stephen G. Swisher,George R. Simon,P. Andrew Futreal,Bonnie S. Glisson,John V. Heymach	2018	2
14	P3.01-91 Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape Viralkumar Vaghani,Sheenu Chandwani,M. Hirschmann,Seyedeh Dibaj,L.L. Landry,Emily Roarty,J. Zhang,W. Rinsurnogkawong,Jeff Lewis,Jes Chauviere Lee,Jack A. Roth,Stephen G. Swisher,John V. Heymach,Thomas Burke,George R. Simon	2018	1
15	Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC) Annikka Weissferdt,Boris Sepesi,Apar Pataer,Neda Kalhor,César A. Moran,William N. William,Xiuning Le,Bonnie S. Glisson,Ferdinandos Skoulidis,George Blumenschein,J. Zhang,Mehmet Altan,David C. Rice,Reza J. Mehran,J.J. Lee,Ara A. Vaporciyan,Don L. Gibbons,Stephen G. Swisher,John V. Heymach,Tina Cascone	2018	4
16	MA19.10 Impact of STK11/LKB1 Genomic Alterations on Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC Ferdinandos Skoulidis,Yasir Y. Elamin,Vincent K. Lam,J. Zhang,Jeff Lewis,Waree Rinsurongkawong,J. Lee,Jack A. Roth,Stephen G. Swisher,Vassiliki A. Papadimitrakopoulou,John V. Heymach	2018	2
17	Genomic Landscape of Atypical Adenomatous Hyperplasia and Their Progression to Lung Adenocarcinomas Smruthy Sivakumar,F Anthony San Lucas,Tina L. McDowell,Wenhua Lang,Li Xu,Junya Fujimoto,J. Zhang,Ignacio I. Wistuba,F.A. Futreal,Junya Fukuoka,Yasushi Yatabe,S. Dubinett,Avrum Spira,Jerry Fowler,Ernie Hawk,Paul Scheet,Humam Kadara	2017	1
18	TCR Repertoire of Lung Cancer: An Association with Tumor Molecular and Clinicopathological Features Alexandre Reuben,Rachel Gittelman,J. Zhang,Chang‐Jiun Wu,Junya Fujimoto,Jaime Rodriguez‐Canales,Stephen G. Swisher,John V. Heymach,H. I. Robins,J.J. Lee,P. Andrew Futreal,Ignacio I. Wistuba	2017	1
19	Lung epithelial cells are essential effectors of inducible resistance to pneumonia Jeffrey O. Cleaver,Dahui You,D R Michaud,Francisco A. Guzmán Pruneda,Miguel M. Leiva Juárez,J. Zhang,P M Weill,Roberto Adachi,Lei Gong,Seyed Javad Moghaddam,Matthew E. Poynter,Michael J. Tuvim,Scott E. Evans	2013	51
20	2727 Sastry Vedam,Lei Dong,J. Zhang,Joe Y. Chang,George Starkschall,James D. Cox,Radhe Mohan,Paul Keall	2006	2

About J. Zhang

J. Zhang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 38 papers that have together received 413 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (5 papers), RNA modifications and cancer (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Cancer Research (101 citations), Oncology (160 citations) and Pulmonary and Respiratory Medicine (162 citations). J. Zhang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include John V. Heymach, David S. Hong, Niamh Coleman, Lingzhi Hong, Xiuning Le, Na Niu, Jian Kuang, Ning Zhang, Jun Yao and Robert C. Bast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact